Therefore, it can be proposed that SIRT3 exhibits oncogenic properties in the context of HFD-induced tumorigenesis and SIRT3 inhibition might be suggested as a strategy to mitigate the tumor promoting effects of HFD. This evidence concerns the gene SIRT3 and neoplasm.